These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 19764822
1. Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy. Rasmussen N, Ditzel HJ. J Proteome Res; 2009 Nov; 8(11):5048-59. PubMed ID: 19764822 [Abstract] [Full Text] [Related]
2. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Urquidi V, Sloan D, Kawai K, Agarwal D, Woodman AC, Tarin D, Goodison S. Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541 [Abstract] [Full Text] [Related]
3. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D, Testa JE, Quigley JP. Oncogene; 2003 Mar 27; 22(12):1783-94. PubMed ID: 12660814 [Abstract] [Full Text] [Related]
4. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78. Jakobsen CG, Rasmussen N, Laenkholm AV, Ditzel HJ. Cancer Res; 2007 Oct 01; 67(19):9507-17. PubMed ID: 17909061 [Abstract] [Full Text] [Related]
9. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M. Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711 [Abstract] [Full Text] [Related]
10. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype. Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L. Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782 [Abstract] [Full Text] [Related]
13. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW, McGuire WL. Cancer Res; 1986 Mar 15; 46(3):1306-17. PubMed ID: 3510721 [Abstract] [Full Text] [Related]
14. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue. Mandeville R, Giroux L, Lecomte J, Chausseau JP, Dumas F, Ajdukovic I, Vidal D, Boury F. Cancer Detect Prev; 1987 Mar 15; 10(1-2):89-100. PubMed ID: 2436777 [Abstract] [Full Text] [Related]
15. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development. Shi B, Vinyals A, Alia P, Broceño C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A. Int J Biochem Cell Biol; 2006 Mar 15; 38(4):544-62. PubMed ID: 16343978 [Abstract] [Full Text] [Related]
17. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas. North SM, Steck PA, Nicolson GL. Cancer Res; 1986 Dec 15; 46(12 Pt 1):6393-9. PubMed ID: 3779654 [Abstract] [Full Text] [Related]
19. Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells. Choi HS, Kim H, Won A, Kim JJ, Son CY, Kim KS, Ko JH, Lee MY, Kim CH, Ryu CJ. Cell Tissue Res; 2008 Aug 15; 333(2):197-206. PubMed ID: 18560898 [Abstract] [Full Text] [Related]